Susquehanna Portfolio Strategies’s Astria Therapeutics ATXS Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,405	Closed	-$398K	–	983
2025 Q4	$398K	Buy	30,405 +3,828	+14%	+$45.7K	0.01%	828
2025 Q3	$193K	Buy	26,577 +8,677	+48%	+$58.7K	﹤0.01%	985
2025 Q2	$95.9K	Buy	+17,900	New	+$86.8K	﹤0.01%	819

Susquehanna Portfolio Strategies's ATXS Position: Q1 2026 in Review

Susquehanna Portfolio Strategies sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 30,405 shares — an estimated $398K sold.

Susquehanna Portfolio Strategies first reported a position in ATXS in Q2 2025 and held it in 3 quarters. The position peaked at $398K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Susquehanna Portfolio Strategies reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 30,405 Astria Therapeutics shares in Q1 2026, an estimated $398K.
Susquehanna Portfolio Strategies first reported a position in Astria Therapeutics in Q2 2025 and held it in 3 quarters.
Susquehanna Portfolio Strategies's Astria Therapeutics position peaked at $398K in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.